Wolfe Research identifies companies with high free cash flow and projected dividend yields, emphasizing their potential for long-term investors. Constellation Energy, Patterson-UTI Energy, and Lennar are featured among the selections.
Dividend growth stocks offer investors a compelling combination of portfolio income and the potential for capital appreciation, according to Wolfe Research. The firm emphasizes that not all dividend payers are created equal. While high dividend payers often represent mature companies distributing profits to shareholders instead of reinvesting in growth, dividend growers, though initially offering modest yields, typically possess robust cash flows and gradually increase their dividend payouts.
These companies present significant opportunities for long-term investors who reinvest dividends, benefiting from both income and price appreciation over time. Chris Senyek, chief investment strategist at Wolfe Research, highlighted the historical outperformance of companies with high free cash flow and rising dividends, noting that they have outpaced the S&P 500 by 5 percentage points. He further explained that these companies provide a margin of safety due to their high cash flows, ensuring the sustainability of future dividends.To identify promising dividend growth opportunities, Wolfe Research focused on companies with high estimated free cash flow and projected dividend yields in 2025. Among their selections was Constellation Energy, a prominent player in the artificial intelligence sector. Shares have surged by 180% in the past year, coupled with a dividend yield of 0.4%. Constellation's success stems from its anticipated role in powering AI and data centers, along with its commitment to rewarding investors through dividend increases and share repurchases. The company's recent acquisition of Calpine, a Houston-based power company, for $16.4 billion, further strengthens its position by adding gas assets and geothermal plants to its portfolio. Another notable pick was Patterson-UTI Energy, an oil rig operator. Despite a 7% decline in share price over the past year, it has shown a 11% gain in 2025. Patterson-UTI boasts a dividend yield of approximately 3.5%. In a recent business update, the company disclosed its share buyback program, investing nearly $300 million in repurchasing shares in 2024. Furthermore, Patterson-UTI returned over $400 million to shareholders last year through dividends and share repurchases, exceeding its target of returning 50% of its cash flow.Finally, Wolfe Research included homebuilder Lennar on its list. While shares have dipped over 5% in the past year, Lennar offers a dividend yield of 1.4%. RBC Capital Markets recently upgraded Lennar to sector perform from underperform, citing the company's potential to accelerate shareholder returns through a land-light strategy and disciplined land expenditure. Lennar is on track to spin off its subsidiary, Millrose Properties, a land banking real estate investment trust, a move expected to streamline its operations and unlock value in ancillary businesses.
DIVIDEND GROWTH INVESTMENT STRATEGIES STOCK MARKET FREE CASH FLOW CONSTELLATION ENERGY PATTERSON-UTI ENERGY LENNAR WALL STREET ANALYSIS
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wolfe Research Downgrades AMD, Citing Data Center GPU ConcernsWolfe Research analyst Chris Caso downgraded Advanced Micro Devices (AMD) to peer perform from outperform, citing concerns about the data center graphics processing unit (GPU) business. Caso lowered his revenue expectations for AMD's data center GPU business in 2025 to $7 billion from at least $10 billion. He also anticipates AMD will not provide 2025 guidance for this business during its fourth-quarter earnings call.
Read more »
Fed to cut interest rates three times by December 2025Fed to cut interest rates three times by December 2025 - Wolfe Research
Read more »
Negative Trial Highlights Need for More Research on Fatigue in Cancer PatientsDr. Maurie Markman discusses a recent trial that investigated the use of methylphenidate for treating fatigue in patients with advanced cancer. While the trial yielded negative results, Dr. Markman emphasizes the importance of conducting such pragmatic trials to address the significant unmet need for effective fatigue management in cancer care.
Read more »
Recent Research Highlights Importance of Sleep, Emotions, and AweThis article explores recent research findings on the impact of sleep, emotions, and awe on human development and well-being. It discusses the connection between consistent sleep routines and emotional regulation in children, the influence of metacognitive self-awareness on hope and self-efficacy, and the need for further study on awe-inspiring experiences in early life.
Read more »
Quitting Vaping: New Research Highlights Promising StrategiesA new report from a team of specialists examines the best ways to help people quit vaping nicotine. Text message interventions and the medication varenicline show potential for successful long-term cessation.
Read more »
New research highlights trends in ADHD diagnosesNew research identifies differing trends in attention-deficit/hyperactivity disorder (ADHD) diagnoses among adolescents and adults, including an increase among adults from 2020 to 2023. The study found a significant downward trends in ADHD incidence among adults from 2016 to 2020 and adolescents from 2016 to 2018.
Read more »